Loading…
Loading…
BIO · NYSE · Healthcare
“With earnings of $27.87 per share against a modest 9.5 multiple, this laboratory equipment manufacturer appears to trade below reasonable estimates of intrinsic value.”
— In the voice of Graham
Estimate fair value using the Graham Number, earnings-based model, and PEG-adjusted valuation. Three independent methods averaged together.
Market Cap
$7.23B
P/E Ratio
9.51
Forward P/E
—
EPS
$27.87
PEG Ratio
-0.05
Book Value
$273.40
Dividend Yield
—
Profit Margin
29.42%
ROE
10.20%
Use the interactive fair value with pre-loaded data for Bio-Rad Laboratories Inc - Class A. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BIO: